James L. Wittliff, Ph.D., FACB, to Present 'Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System' at the Association for Molecular Pathology Conference, October 30
...Xceed Molecular will feature Ziplex automated gene-expression system a... conference booth 519 ...WELLESLEY Mass. Oct. 28 /- Xceed Molecular a pioneer i... Visitors to the AMP conference will have a great opportunity to hear...
Date:10/28/2008
Xceed Molecular will feature Ziplex automated gene-expression system at the
conference, booth 519
WELLESLEY, Mass., Oct. 28 /PRNewswire/ -- Xceed Molecular, a pioneer in
the development of cost-effective, easy-to-use gene-expression analysis
systems, announced that renowned breast cancer researcher and Xceed
collaborator, Dr. James L. Wittliff, a professor in the Department of
Biochemistry and Molecular Biology at the University of Louisville, will be
a featured speaker at the Association for Molecular Pathology (AMP) Annual
Meeting. Dr. Wittliff's presentation, "Predicting Breast Cancer Outcome
with Gene Expression Signatures on the Ziplex System" is scheduled from 3
to 4 pm on Thursday, October 30, in the Dallas 1-2 Room. The company also
announced that it will feature its award-winning Ziplex Automated
Gene-Expression System at the conference in booth 519. Currently available
for research use only, the Ziplex System is the first integrated system for
automated gene-expression analysis. It comprises an automated hybridization
workstation, TipChip consumable arrays, reagents, and analysis/reporting
software. The AMP 2008 Annual Meeting and Exhibits takes place October 29
through November 2, 2008, at the Gaylord Texan Resort & Convention Center
in Grapevine, Texas.
"Visitors to the AMP conference will have a great opportunity to hear
Dr. Wittliff's presentation on his exciting research predicting risk of
breast cancer recurrence and to learn how the Ziplex System is integral to
his study process," said Xceed's President and CEO, David Deems. "The
Ziplex System is rapidly becoming the standard platform for the nation's
leading institutions performing translational research. Xceed designed the
Ziplex System with turnkey functionality and significant advances in
automation, array format, parallel sample processing, and analytics to
minimize complexity, user interaction, and variability between users and
sites."
Accor
'/>"/>
SOURCE Xceed Molecular Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price2.
Orchid Cellmark Appoints James F. Smith Chief Financial Officer3.
Immunotec Inc. announces appointment of President & CEO James A. Northrop4.
Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence5.
James Webb Space Telescope marks successful completion6.
IRIDEX Announces James Mackaness Will Be Chief Financial Officer7.
Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board8.
PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference9.
Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference10.
Warner Chilcott Reports the Death of Its Director James Andress11.
James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
(Date:11/9/2009)..., PLYMOUTH, Mass., Nov. 9 Har...announced today that the company sponsored 48-pati... the U.S. and one site in India using the company,... to treat patients with non-reconstructable Critic...Mark D. Iafrati, M.D. Chief of Vascular Surgery at...
(Date:11/9/2009)..., WASHINGTON, Nov. 9 /PRNewswire-USNewswire/ ...e American Humanist Association, held a panel disc... controversial emerging technologies in biomedical...ed by Jonathan Moreno and Andrew Light, both of th... issues from ethical and political angles. ,, ...
(Date:11/9/2009)..., BEIJING, Nov. 9 /PRNewswire-Asia-FirstC...), ("Yongye or "the Company") a leading manufactur... plant and animal nutrient products in the,People,... will conduct a,conference call at 10:00 a.m. East...mber 16, 2009 to discuss results for the quarter e...
(Date:11/9/2009)..., SCHIEDLBERG, Austria, November 9 /PRNew...ver the world have been working on the development...rect communication channel,between the brain and a...zed,patients to communicate or to control devices ...ng the last years some patients have been supervis...
Breaking Biology Technology:Harvest Technologies Announces Completion of Patient Enrollment in its Randomized, Controlled, Double Blind Multicenter IDE Non-Reconstructable Critical Limb Ischemia Trial 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2HeLa Cell Slide from ProSci, Inc
EL4 Cell Slide from ProSci, Inc
IHC Select TE Buffer pH 9.0 [Antigen/ Epitope Retrieval Reagent], 10x from CHEMICON
Hep G2 Cell Slide from ProSci, Inc
Biology Products: